SecBot SecBot
8-K ·Filed Oct 9, 2026

GBCS

SELECTIS HEALTH, INC.
BULLISH
Impact 8/10
Horizonimmediate Processed16d 23h ago SEC0001493152-26-046568
8-K material event: Items 2.01, 5.01
Actionable Insight ▲ Bullish

The company is now a private acquisition vehicle under Black Pearl control. Monitor for future merger or acquisition announcements that could create a new public listing or exit event for the acquirer's stakeholders.

DirectionBullish
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

Executive Summary

Black Pearl Equities completed its acquisition of Selectis Health (GBCS) via a short-form merger on October 5, 2026, taking the company private. All remaining public shares were cashed out at $5.75/share, and the company will be delisted from OTCQB and deregister its securities. The merger was funded by an $18.23M term loan facility secured against substantially all assets, and the new bylaws designate the company as an acquisition vehicle for future acquisitions.

Key Facts

  • Merger completed on October 5, 2026, with the company becoming a wholly owned subsidiary of Black Pearl Equities II, LLC.
  • Each remaining public share converted into $5.75 cash; aggregate consideration ~$17,635,589.
  • Company assumed $18,226,250 in term loans at 5.0% interest, maturing August 28, 2031, secured by substantially all assets.
  • Shares will no longer be quoted on OTCQB; Form 15 to be filed to terminate SEC registration and reporting obligations.
  • Prior board and interim CFO replaced by Abraham Schwartz and Zalman Schapiro as directors and officers.
  • Amended articles authorize only 1,000 shares of no-par common stock; new bylaws restrict share transfer and position the company as an acquisition vehicle.

Financial Impact

Total cash consideration of approximately $17,635,589 paid to public shareholders, funded by $18,226,250 in term loans at 5.0% fixed interest.

dilutiondebtcash

Risk Factors

  • The $18.2M term loan is secured by substantially all assets; an event of default could trigger a further change of control via the collateral agent's remedies on pledged equity.
  • No public market or trading liquidity remains — shares are delisted and will be deregistered.
  • No financial performance data or guidance provided; the company's post-merger financial health is opaque without ongoing public filings.

Investment Themes

Real Estate

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-046568
Exhibit: ex3-2.htm0001493152-26-046568
Exhibit: ex3-1.htm0001493152-26-046568
Document: 0001493152-26-046568-index-headers.html0001493152-26-046568
Document: 0001493152-26-046568-index.html0001493152-26-046568
Document: 0001493152-26-046568.txt0001493152-26-046568
6 reports for GBCS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for GBCS — sortable, filterable
TypeNow
Oct 9, 2026
16d ago
15-12G
BEARISH ★ 7/10
—awaiting T+20——
Oct 9, 2026
16d ago
8-K
BULLISH ★ 8/10
—awaiting T+20——
Sep 8, 2026
6w ago
8-K
BULLISH ★ 7/10
$5.74 $5.73▼ −0.17%▼ −2.37%—
May 20, 2026
22w ago
8-K
BEARISH ★ 6/10
$3.31 $3.25▲ +1.81%▲ +2.55%—
May 7, 2026
24w ago
8-K
MIXED ★ 5/10
$3.14 $3.10▼ −1.27%▼ −1.30%—
Mar 19, 2026
31w ago
8-K
NEUTRAL ★ 3/10
$4.05 $4.40▲ +8.64%▲ +1.02%—
Showing 6 of 6

US Market Status

Market Open — Closes in 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 9, 2026